Saturday April 20, 2024 | Last Update: April 20, 2024 EDT
Pfizer, Inc. is already in advanced talks to acquire Allergan Plc that would value the Botox maker as high as $150 billion, people familiar with the matter told Bloomberg. The people said, though, that a final agreement could be delayed, as well as a change in the terms of the transaction due to the U.S. Treasury Department’s changes on the rules on tax inversion deals.
Read more >>
Pfizer, Inc. and Allergan PLC are in talks about a possible merger of the two companies, people familiar with the matter told The Wall Street Journal. The deal, if it pushes through, would be one of the largest deals in the history of the healthcare industry.
Just In
Most Read
1
2
3
4
5
